Elham Hatami

804 total citations
20 papers, 637 citations indexed

About

Elham Hatami is a scholar working on Molecular Biology, Cancer Research and Biomaterials. According to data from OpenAlex, Elham Hatami has authored 20 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Biomaterials. Recurrent topics in Elham Hatami's work include Nanoparticle-Based Drug Delivery (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Natural Compound Pharmacology Studies (3 papers). Elham Hatami is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Natural Compound Pharmacology Studies (3 papers). Elham Hatami collaborates with scholars based in United States and Iran. Elham Hatami's co-authors include Murali M. Yallapu, Subhash C. Chauhan, Meena Jaggi, Prashanth K.B. Nagesh, Pallabita Chowdhury, Sheema Khan, Bilal Bin Hafeez, Vivek K. Kashyap, Nirnoy Dan and Bernd Meibohm and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Elham Hatami

19 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elham Hatami United States 13 256 155 152 84 78 20 637
Xiaojun Shi China 16 297 1.2× 170 1.1× 118 0.8× 74 0.9× 52 0.7× 40 947
Guohua Zheng China 18 342 1.3× 200 1.3× 130 0.9× 93 1.1× 114 1.5× 52 877
Ana Carolina Santos de Souza Brazil 16 302 1.2× 81 0.5× 166 1.1× 66 0.8× 59 0.8× 26 741
Tullayakorn Plengsuriyakarn Thailand 14 309 1.2× 171 1.1× 149 1.0× 50 0.6× 121 1.6× 31 772
Dongyang Zhao China 15 277 1.1× 179 1.2× 208 1.4× 45 0.5× 90 1.2× 17 610
Junjian Li China 15 274 1.1× 143 0.9× 104 0.7× 100 1.2× 34 0.4× 27 699
Xuejun Xia China 21 386 1.5× 258 1.7× 172 1.1× 47 0.6× 44 0.6× 41 926
Xiaoju Zhou China 16 370 1.4× 228 1.5× 145 1.0× 94 1.1× 37 0.5× 28 812

Countries citing papers authored by Elham Hatami

Since Specialization
Citations

This map shows the geographic impact of Elham Hatami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Hatami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Hatami more than expected).

Fields of papers citing papers by Elham Hatami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elham Hatami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Hatami. The network helps show where Elham Hatami may publish in the future.

Co-authorship network of co-authors of Elham Hatami

This figure shows the co-authorship network connecting the top 25 collaborators of Elham Hatami. A scholar is included among the top collaborators of Elham Hatami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elham Hatami. Elham Hatami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hatami, Elham, et al.. (2025). 162 HER2-ultra low and HER2-null Breast Cancers, Incidence and Correlation with Clinicopathologic Parameters. Laboratory Investigation. 105(3). 102386–102386. 1 indexed citations
2.
Hatami, Elham, Prashanth K.B. Nagesh, Mohammed Sikander, et al.. (2022). Tannic Acid Exhibits Antiangiogenesis Activity in Nonsmall-Cell Lung Cancer Cells. ACS Omega. 7(27). 23939–23949. 16 indexed citations
3.
Hatami, Elham, Prashanth K.B. Nagesh, Neeraj Chauhan, et al.. (2022). In Situ Nanoparticle Self-Assembly for Combination Delivery of Therapeutics to Non-Small Cell Lung Cancer. ACS Applied Bio Materials. 5(3). 1104–1119. 9 indexed citations
4.
Eghbalian, Fatemeh, et al.. (2021). Clofibrate in the Treatment of the Non-hemolytic Hyperbilirubinemia in Preterm Neonates in Western Iran. SHILAP Revista de lepidopterología.
6.
Nagesh, Prashanth K.B., Pallabita Chowdhury, Elham Hatami, et al.. (2020). Tannic acid inhibits lipid metabolism and induce ROS in prostate cancer cells. Scientific Reports. 10(1). 980–980. 53 indexed citations
7.
Hatami, Elham, Meena Jaggi, Subhash C. Chauhan, & Murali M. Yallapu. (2020). Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1874(1). 188381–188381. 96 indexed citations
8.
Hatami, Elham, Prashanth K.B. Nagesh, Meena Jaggi, Subhash C. Chauhan, & Murali M. Yallapu. (2020). Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer. European Journal of Pharmacology. 888. 173486–173486. 40 indexed citations
9.
Hatami, Elham, et al.. (2020). Pectin-Tannic Acid Nano-Complexes Promote the Delivery and Bioactivity of Drugs in Pancreatic Cancer Cells. Pharmaceutics. 12(3). 285–285. 45 indexed citations
10.
Hatami, Elham, Ying Mu, Subhash C. Chauhan, et al.. (2019). Mannose-decorated hybrid nanoparticles for enhanced macrophage targeting. Biochemistry and Biophysics Reports. 17. 197–207. 62 indexed citations
11.
Hatami, Elham, Prashanth K.B. Nagesh, Pallabita Chowdhury, et al.. (2019). Abstract 1871: Tannic acid: A natural anticancer agent for non-small cell lung cancer. Cancer Research. 79(13_Supplement). 1871–1871. 2 indexed citations
12.
Nagesh, Prashanth K.B., Pallabita Chowdhury, Elham Hatami, et al.. (2019). Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence. ACS Applied Materials & Interfaces. 11(42). 38537–38554. 41 indexed citations
13.
Hatami, Elham, Prashanth K.B. Nagesh, Pallabita Chowdhury, et al.. (2019). Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy. ACS Biomaterials Science & Engineering. 5(5). 2343–2354. 14 indexed citations
14.
Nagesh, Prashanth K.B., Pallabita Chowdhury, Elham Hatami, et al.. (2018). miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy. Cancers. 10(9). 289–289. 43 indexed citations
15.
Hatami, Elham, Prashanth K.B. Nagesh, Pallabita Chowdhury, et al.. (2018). Tannic Acid-Lung Fluid Assemblies Promote Interaction and Delivery of Drugs to Lung Cancer Cells. Pharmaceutics. 10(3). 111–111. 17 indexed citations
16.
Nagesh, Prashanth K.B., Elham Hatami, Pallabita Chowdhury, et al.. (2018). Tannic Acid Induces Endoplasmic Reticulum Stress-Mediated Apoptosis in Prostate Cancer. Cancers. 10(3). 68–68. 52 indexed citations
17.
Chowdhury, Pallabita, Prashanth K.B. Nagesh, Elham Hatami, et al.. (2018). Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells. Journal of Colloid and Interface Science. 535. 133–148. 131 indexed citations
18.
Hatami, Elham, Prashanth K.B. Nagesh, Pallabita Chowdhury, et al.. (2018). Abstract LB-400: Tannic acid induces prostate cancer cell death via unfolded protein response (UPR) and modulation of CHOP. Cancer Research. 78(13_Supplement). LB–400. 1 indexed citations
19.
Chowdhury, Pallabita, Prashanth K.B. Nagesh, Elham Hatami, et al.. (2018). Abstract 4658: Novel paclitaxel medical nanoparticle formulation for breast cancer. Cancer Research. 78(13_Supplement). 4658–4658. 1 indexed citations
20.
Ghiasi, Mina, Majid M. Heravı, & Elham Hatami. (2012). Quantum mechanical study of energetics and mechanisms of cis–trans isomerization of some four-membered heterocycles. Journal of the Iranian Chemical Society. 10(2). 257–263. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026